Journal article Open Access

Pandemia e vaccini. L'irrisolvibile antagonismo tra scienza aperta e proprietà intellettuale

Caso, Roberto


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">ita</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Open Science</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Intellectual Property</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Vaccines</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Patents</subfield>
  </datafield>
  <controlfield tag="005">20210524134818.0</controlfield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">https://www.robertocaso.it/2021/05/19/pandemia-e-vaccini-lirrisolvibile-antagonismo-tra-scienza-aperta-e-proprieta-intellettuale/</subfield>
  </datafield>
  <controlfield tag="001">4783183</controlfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">554076</subfield>
    <subfield code="z">md5:58bcdc38ee02e8d2bc5a022dfda8499a</subfield>
    <subfield code="u">https://zenodo.org/record/4783183/files/LTRP_44_Caso_24 05 21_def.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2021-05-24</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-trentolawtechgroup</subfield>
    <subfield code="o">oai:zenodo.org:4783183</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Università di Trento</subfield>
    <subfield code="0">(orcid)0000-0002-9220-6449</subfield>
    <subfield code="a">Caso, Roberto</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Pandemia e vaccini. L'irrisolvibile antagonismo tra scienza aperta e proprietà intellettuale</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-trentolawtechgroup</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by-sa/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution Share Alike 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;This paper aims at critically addressing the issue of intellectual property in the biomedical and health fields, focusing on the equitable and rapid distribution of anti-COVID-19 vaccines on a global scale. The main allegation is not new: open science is incompatible with policies aimed at extending and strengthening intellectual property. However, this same thesis deserves further attention in relation to the ongoing public debate and national and international policy choices. The paper starts from the refutation of the arguments in favour of private patents on vaccines (paragraph 2), then it provides an overview on of the debate on downstream policies (paragraph 3) and discusses some upstream policies (paragraph 4); some conclusions follow (paragraph 5).&lt;/p&gt;

&lt;p&gt;Questo scritto intende affrontare criticamente il tema della propriet&amp;agrave; intellettuale in campo biomedico e sanitario, con particolare riferimento alla questione dell&amp;rsquo;equa e rapida distribuzione su scala globale dei vaccini anti-COVID-19. La tesi di fondo non &amp;egrave; nuova: la scienza aperta &amp;egrave; inconciliabile con politiche di estensione e rafforzamento della propriet&amp;agrave; intellettuale. Pur non essendo nuova, la tesi merita un approfondimento in relazione al dibattito pubblico in corso e alle scelte politiche nazionali e internazionali. Si prender&amp;agrave; le mosse dalla confutazione degli argomenti a favore di brevetti privati sui vaccini (paragrafo 2), per poi offrire una sintesi del dibattito sulle politiche a valle (paragrafo 3), discutere alcune politiche a monte (paragrafo 4) e infine svolgere alcune conclusioni (paragrafo 5).&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.4783182</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.4783183</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
131
64
views
downloads
All versions This version
Views 131131
Downloads 6464
Data volume 35.5 MB35.5 MB
Unique views 105105
Unique downloads 5959

Share

Cite as